Industry-Funded CME activities continue to focus on arming physicians with the latest scientific research data regarding novel, often expensive, diagnostic and treatment approaches. However, physicians may fail to translate that information into clinical practice if hospital regulations or patients' lack of access to facilities present barriers. Furthermore, the newest drugs are not always the most beneficial for patients, especially if those patients are uninsured or their insurance
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.